Privileged scaffold repurposed: the evolving role of quinolone derivatives in antiviral therapy
- 5 October 2025
- journal article
- review article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 130, 130427
Abstract
No abstract availableKeywords
Funding Information
- Taishan Scholar Foundation of Shandong Province (tsqn202103108)
- Taishan Scholar Project of Shandong Province (tstp20240852)
- National Key Research and Development Program of China
- Ministry of Science and Technology of the People's Republic of China (2023YFC2606500)
This publication has 60 references indexed in Scilit:
- Hepato-selective dihydroquinolizinones active against hepatitis A virus in vitro and in vivoAntiviral Research, 2025
- Exploring 4-quinolone-3-carboxamide derivatives: A versatile framework for emerging biological applicationsBioorganic Chemistry, 2025
- Herpes Zoster Recurrence: A Narrative Review of the LiteratureDermatology and Therapy, 2024
- High‐Throughput Miniaturized Synthesis of PROTAC‐Like MoleculesSmall, 2024
- Acyclovir‐resistant HSV‐1 isolates among immunocompromised patients in southern Taiwan: Low prevalence and novel mutationsJournal of Medical Virology, 2023
- Inhibition of influenza A virus replication by a marine derived quinolone alkaloid targeting virus nucleoproteinJournal of Medical Virology, 2023
- DNA polymerases of herpesviruses and their inhibitors2021
- Influenza Virus Resistance to Antiviral Therapy2013
- Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsidBioorganic & Medicinal Chemistry, 2011
- Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitroBioorganic & Medicinal Chemistry, 2008